Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1098

1.
2.

Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2566-73.

PMID:
10937568
3.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
4.
5.

The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

Yildirim N, Sahin A, Gultekin S.

J Glaucoma. 2008 Jan-Feb;17(1):36-9. doi: 10.1097/IJG.0b013e318133fb70.

PMID:
18303382
6.

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.

Ophthalmology. 2007 Dec;114(12):2244-51. Epub 2007 Apr 25.

PMID:
17459480
7.

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.

PMID:
15016559
8.

Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.

Ophthalmology. 2005 Feb;112(2):262-6.

PMID:
15691561
9.

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

Am J Ophthalmol. 2003 Jan;135(1):55-63.

PMID:
12504698
10.

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.

PMID:
17415690
12.

A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

Choplin N, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S19-25.

PMID:
15016558
13.
14.

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

Cantor LB, WuDunn D, Cortes A, Hoop J, Knotts S.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S12-8.

PMID:
15016557
15.

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

Clin Ther. 2004 Jan;26(1):84-91.

PMID:
14996520
16.

Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.

DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C.

Surv Ophthalmol. 2001 May;45 Suppl 4:S353-60.

PMID:
11434938
17.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
18.

Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.

Centofanti M, Oddone F, Gandolfi S, Hommer A, Boehm A, Tanga L, Sangermani C, Sportelli V, Haustein M, Manni G, Rossetti L.

Am J Ophthalmol. 2010 Oct;150(4):575-80. doi: 10.1016/j.ajo.2010.05.003. Epub 2010 Aug 4.

PMID:
20688314
19.

A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.

Adv Ther. 2006 May-Jun;23(3):385-94.

PMID:
16912020
20.

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.

Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23.

PMID:
16799034

Supplemental Content

Support Center